Major depression now believed to be caused by abnormalities in immune cells of the brain; may revolutionize next-generation psychiatric medication treatment, according to Hebrew University of Jerusalem researchers.
“Microglia” cells in the brain, acting as first and main form of active immune defense of central nervous system, may be a key to causing depression. Latest theory opens door to development of a new generation of anti-depressant medications.
Major depression, which afflicts one in six people at some point in their life, is the leading global cause of disability – surpassing cardiovascular and respiratory diseases, cancer and HIV/AIDS combined.
In a groundbreaking theoretical review paper published in the peer-reviewed journal, Trends in Neurosciences, researchers from the Hebrew University of Jerusalem suggest that “progress in the understanding of the biology of depression has been slow,” requiring expanding beyond the “abnormalities in the functioning of neurons.” The contribution of other brain cells — often neglected by researchers — may be more relevant in causing depression, according to psychobiology Prof. Raz Yirmiya, director of the Hebrew University’s Laboratory for PsychoNeuroImmunology, and senior author of the journal’s paper, titled “Depression as a microglial disease.” http://authors.elsevier.com/a/1RpN8botpXeIf
Recent research at the Hebrew University’s laboratory and elsewhere finds that some forms of depression may result from malfunctioning brain cells, termed “microglia.” “However,” Prof. Yirmiya cautions, “this does not mean that all sub-types of depression or other psychiatric diseases are originated by abnormalities in these cells.”
Prof. Yirmiya’s new research could have a profound impact on the future development of anti-depressant medications. Present drugs do not always have the desired effect on patients, so there is an urgent need to discover novel biological mechanisms and drug targets for diagnosing the root cause of depression and for treating depressed patients appropriately.
In Trends in Neuroscience, the Hebrew University researchers claim that diseased microglia can cause depression and drugs that restore the normal functioning of these cells can be effective as fast-acting anti-depressants.
Microglia, which comprise 10% of all brain cells, are the brain’s immune cells. They fight infectious bacteria and viruses in the brain. They also promote repairing and healing processes of damages caused by brain injury and trauma.
“Our views on microglia have dramatically changed over the last decade,” Prof. Yirmiya says. “We now know that these cells play a role in the formation and fine-tuning of the connections between neurons (synapses) during brain development, as well as in changes of these connections throughout life. These roles are important for normal brain and behavioral functions, including pain, mood and cognitive abilities.”
“Studies in humans, using post-mortem brain tissues or special imaging techniques, as well as studies in animal models of depression, demonstrated that when the structure and function of microglia change, these cells can no longer regulate normal brain and behavior processes and this can lead to depression,” Prof. Yirmiya says.
Indeed, changes in microglia occur during many conditions associated with high incidence of depression, including infection, injury, trauma, aging, autoimmune diseases such as multiple sclerosis and neurodegenerative diseases such as Alzheimer’s disease. In these conditions, microglia assume an “activated” state in which they become big and round, and secrete compounds that orchestrate an inflammatory response in the brain.
The shape and function of microglia can be also changed following exposure to chronic unpredictable psychological stress, which is one of the leading causes of depression in humans. Importantly, research in Prof. Yirmiya’s laboratory recently discovered that following exposure to such stress, some microglia die and the remaining cells appear small and degenerated.
These findings have both theoretical and clinical implications. According to the new theory, either activation or decline of microglia can lead to depression. Therefore, the same class of drugs cannot treat the disease uniformly.
Prof. Yirmiya asserts that a personalized medical approach should be adopted in which the status of the microglia in the individual patient should be established first. Based on this initial assessment, treatment with drugs that either inhibit the over-active microglia or stimulate the suppressed microglia should be employed.
Read more: New Depression Diagnosis and Treatment
The Latest on: Depression
[google_news title=”” keyword=”depression” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Depression
- We May Finally Know Why Magnetic Stimulation on The Brain Can Ease Depressionon May 27, 2023 at 11:00 pm
Stimulating the brain with magnetic fields can help relieve the symptoms of depression in some people, but scientists haven't been sure precisely why it works.
- I used to be married to my husband. Now, I’m married to his depressionon May 27, 2023 at 2:27 pm
What happens when the person you married becomes someone you don’t even know? Or like? Or worse yet, what happens when they no longer love you? Loving someone with depression is complicated. It can be ...
- Ways to Deal with Your Depressionon May 27, 2023 at 12:32 pm
Almost all of us have been through a spell of depression at some phase of our lives. Depression makes us feel low for an extended period of time and often drains our hope, energy, and drive. About 3.
- Can You Treat Depression With Cannabis? It's Complicatedon May 27, 2023 at 10:20 am
This article was originally published on Cannabis.net and appears here with permission. Depression is a pervasive mental health issue that affects millions of people worldwide. It's a complex and ...
- Anger, sleep issues, depression: How PTSD took control of this soldier’s lifeon May 27, 2023 at 10:08 am
Kyle Prellberg served two combat tours as a sniper for the U.S. Army in Iraq and Afghanistan. In 2012, he was wounded by shrapnel from a rocket-propelled grenade that struck his vehicle, and he was ...
- Depression more common in surburban single-family houses than in city centres: new reporton May 27, 2023 at 3:16 am
Urban areas are more affected by depression than rural areas, but dense inner-city centres are not the worst place to live. A new study has found that residents of suburbs are more at risk of depressi ...
- Depression is an illness — and it's time we got real about thaton May 26, 2023 at 10:59 pm
Though it's none of my business, I wonder how his after-treatment is going. Does he see his depression as a chronic thing, one that he'll work to ward off throughout his life? How is his self-care? Is ...
- Marijuana use linked to depression, bipolar disorder and schizophrenia in young men, growing evidence findson May 26, 2023 at 7:49 pm
A growing body of research links marijuana use among some young adults to mental health issues such as schizophrenia, bipolar disorder and depression.
- Ketamine Shows Promise for Hard-to-Treat Depression in New Studyon May 26, 2023 at 10:50 am
Research this week presents the most robust evidence to date that ketamine is at least as effective as electroconvulsive therapy for patients with treatment-resistant depression who do not have ...
- The Most Common Depression Medications, Explainedon May 26, 2023 at 8:57 am
Here are some of the most common depression medications: ...
via Bing News